PATENT CLAIM ANALYSIS

Application Number: 15745903
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "734000"]

Abstract:
Peritoneal therapeutic fluid comprising one or more of a biocompatibility enhancing agent (BCA) that is selected from the group consisting of a polyphenolic compound, a metabolite of a polyphenolic compound which is obtained by metabolization in the human or animal body, a salt or a glycoside of a polyphenolic compound.

Claim (Index 9):
A peritoneal therapeutic fluid according to  claim 1 , wherein the PEG or the derivative of PEG is selected from the group comprising PEG 600, mPEG 600, PEG 1000, mPEG 1000, PEG 1450, mPEG 1450, PEG 3350 and mPEG 3350, or the like.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.48649
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15523591', '11997765', '14084793', '13984991', '11554056']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7196164685549112
- 35 USC 102 Novelty (BERT): 0.5006424130178807
- Combined Prediction Score: 0.6977190630012082
- Mean Citation Score: 187.43985
- Max Citation Score: 194.85373
- Similarity Product: 118.7960406070614

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test